首页> 外文期刊>European journal of ophthalmology >Visual outcome after excimer laser refractive surgery in adult patients with amblyopia.
【24h】

Visual outcome after excimer laser refractive surgery in adult patients with amblyopia.

机译:成人弱视患者准分子激光屈光手术后的视觉结果。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE. To evaluate the visual and refractive outcome in adult patients wi th refractive and anisometropic amblyopia treated with photorefractive keratectomy. METHODS. An interventional non-comparative study was performed on 50 consecutive patients with amblyopia treated with photorefractive keratectomy. Sixty-eight eyes of 18 participants with bilateral refractive amblyopia and 32 participants with unilateral anisometropic amblyopia were studied. The photorefractive keratectomy was performed with MEL 70 G-Scan excimer laser. Follow-up was 1, 3, 6, and 12 months after the treatment. The mean outcome measures were uncorrected visual acuity (UCVA), best spectacle corrected visual acuity (BCVA), refraction, and corneal transparency. RESULTS. In 64.7% of eyes, the UCVA at 12 months after the treatment was better than or equal to thei r preoperative BCVA. A total of 82.4% of eyes improved their BCVA one or more lines. No eye lost lines of BCVA, 17.6% remained unvaried, 50% gained one line, 20.6 % gained two lines, and 11.8% gained three lines of BCVA. The number of lines gained correlated strongly with diopters of anisometropia between eyes (p<0.01). The mean sphere changed from -5.62+/-3.37 D to -0.47+/-1 D, mean cylinder varied from -2.36+/-1.57 to -0.18+/-0.41 D, and the spherical equivalent varied from -6.82+/-3.1 to -0.45+/-1.08 D. No clinically significant haze was observed. CONCLUSIONS. Excimer laser refractive surgery appears to be a safe and efficient procedure in the treatment of ametropic and anisometropic amblyopia in adults. Adult patients with anisometropic and refractive amblyopia could benefit from the refractive treatment with significant improvement of the visual acuity.
机译:目的。为了评估用屈光性角膜切除术治疗屈光性和屈光参差性弱视的成年患者的视觉和屈光结果。方法。一项对50例接受屈光性角膜切除术治疗的弱视患者的干预性非对比研究。研究了18例双侧屈光性弱视和32例单眼屈光参差性弱视的68只眼。用MEL 70 G-Scan准分子激光进行屈光性角膜切除术。治疗后1、3、6和12个月进行随访。平均结局指标为未矫正视力(UCVA),最佳眼镜矫正视力(BCVA),屈光度和角膜透明度。结果。在64.7%的眼睛中,治疗后12个月的UCVA优于或等于术前BCVA。总计82.4%的眼睛使BCVA改善了一条或多条。没有BCVA失明线,保持17.6%不变,50%获得一线,20.6%获得两线,11.8%获得三线BCVA。获得的线数与眼睛之间屈光参差的屈光度密切相关(p <0.01)。平均球面度从-5.62 +/- 3.37 D更改为-0.47 +/- 1 D,平均圆柱度从-2.36 +/- 1.57更改为-0.18 +/- 0.41 D,球形当量范围从-6.82 + / -3.1至-0.45 +/- 1.08D。未观察到临床上显着的雾度。结论。准分子激光屈光手术似乎是治疗成人屈光参差和屈光参差性弱视的一种安全有效的方法。屈光参差和屈光性弱视的成年患者可从屈光治疗中受益,并显着改善视力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号